CARRA Registry Research Network for SJIA-LD (CARE-NETS) Study

Disease Area:
Juvenile Idiopathic Arthritis (JIA)

Biosample Status:
Biosample Available

About the CARE-NETS Study

Over the past decade, children with systemic JIA (sJIA) have increasingly been found to have a life-threatening lung disease. Still, the causes and best treatments for this deadly complication are unknown. This lung disease is known as sJIA-LD. In general, children suffering from SJIA-LD have uncontrolled inflammation in their lungs making it harder to move air in and out of their lungs to provide enough oxygen in their bloodstream.

Researchers at Cincinnati Children’s Hospital, with help from CARRA, are working on a project called the “CARRA Registry Research Network for SJIA-LD” (CARE-NETS) that will allow sJIA-LD data to be collected at several hospitals in the US and Canada to understand this disease better.

Researchers want to learn:

  • How lung disease develops and progresses over time in children with SJIA
  • Biomarker patterns among sJIA-LD kids, using blood samples

Even though the number of sJIA-LD children is increasing, it is still a rare complication. Researchers and doctors need to rely on information from the entire patient group to identify trends and help determine which medications are most appropriate for individual patients. This project will launch the first research network to collect clinical data and blood samples from children with sJIA-LD through the CARRA Registry. CARE-NETS is an essential first step to finding the cause of sJIA-LD, which will be done using the CARRA network.

Study Updates and Findings

About the Participants

  • Children with sJIA. Children must be diagnosed with sJIA by their physician and with any disease duration. Children can be existing or new CARRA Registry participants.
  • Lung disease related to sJIA may be suspected, probable or definite, as defined by the study team.

About the Study Team

This study is funded through a CARRA-Arthritis Foundation Large Grant. Additional support is provided in part by the Systemic JIA Foundation.

Lead researchers (*Principal Investigator):

  • Grant Schulert*, MD, PhD, Cincinnati Children’s Hospital Medical Center
  • Yukiko Kimura, MD, Hackensack

To learn more about this project, please contact [email protected].

Related Research Projects

Disease Area:
Juvenile Idiopathic Arthritis (JIA)

Advancing the Science of Pediatric Patient-Reported Outcomes for Children with Chronic Disease (PEPR)

Validation of patient-reported outcomes in chronic diseases.

Disease Area:
Juvenile Idiopathic Arthritis (JIA)

Precision Decisions

Study to develop a biomarker tool to predict response to treatment in polyarticular JIA.

Disease Area:
Juvenile Idiopathic Arthritis (JIA)

Disease Recapture after Drug Discontinuation and Flare in Juvenile Idiopathic Arthritis (Recapture-JIA)

Study to characterize rates and predictors of disease recapture in children with JIA who re-start medication to treat flares.